[CCAFU french national guidelines 2016-2018 on renal cancer]

K Bensalah; L Albiges; J-C Bernhard; P Bigot; T Bodin; R Boissier; J-M Corréas; P Gimel; J-A Long; F-X Nouhaud; I Ouzaïd; P Paparel; N Rioux-Leclercq; A Méjean

doi:10.1016/S1166-7087(16)30702-3

[CCAFU french national guidelines 2016-2018 on renal cancer]

Prog Urol. 2016 Nov:27 Suppl 1:S27-S51. doi: 10.1016/S1166-7087(16)30702-3.

[Article in French]

Authors

K Bensalah¹, L Albiges², J-C Bernhard², P Bigot², T Bodin², R Boissier², J-M Corréas², P Gimel², J-A Long², F-X Nouhaud², I Ouzaïd², P Paparel², N Rioux-Leclercq², A Méjean²

Affiliations

¹ Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017 Paris, France. Electronic address: [email protected].
² Comité de cancérologie de l'Association française d'urologie, groupe rein, maison de l'urologie, 11, rue Viète, 75017 Paris, France.

PMID: 27846932
DOI: 10.1016/S1166-7087(16)30702-3

Abstract

The previous guidelines from the Cancer Committee of the Association Française d'Urologie were published in 2013. We wanted this new version to be simple, clear and straightforward. All significant recent publications on kidney cancer have been included. The main changes compared to 2013 are the following: © 2016 Elsevier Masson SAS. All rights reserved.

Keywords: Anti-angiogenics; Anti-angiogéniques; Cancer du rein; Chirurgie; Classification; Guidelines; Kidney cancer; Recommandations; Surgery.

Publication types

Practice Guideline

MeSH terms

Humans
Kidney Neoplasms / diagnosis*
Kidney Neoplasms / therapy*